Summary
Since their synthesis in the late 1800s paracetamol (acetaminophen) and phenacetin have followed divergent pathways with regard to their popularity as mild analgesic/antipyretic drugs. Initially, paracetamol was discarded in favour of phenacetin because the latter drug was supposedly less toxic. Today the opposite is true, and paracetamol, along with aspirin, has become one of the two most popular ‘over-the-counter’ non-narcotic analgesic agents. This marked increase in the wide approval attained by paracetamol has been accompanied by the virtual commercial demise of phenacetin because of its role, albeit somewhat circumstantial, in causing analgesic nephropathy.
Both paracetamol and phenacetin are effective mild analgesics, suitable for treating mild to moderate pain, and their actions are broadly comparable with those of aspirin and related salicylates, although they do not appear to possess significant anti-inflammatory activity. Since a major portion of a dose of phenacetin is rapidly metabolised to paracetamol, it seems possible that phenacetin owes some of its therapeutic activity to its main metabolite, paracetamol, whereas its most troublesome side effect (methaemoglobinaemia) is due to another metabolite, p-phenetidine. The mechanism of action of paracetamol is poorly defined, although it has been speculated that it may selectively inhibit prostaglandin production in the central nervous system, which would account for its analgesic/antipyretic properties. The lack of any significant influence on peripheral cyclo-oxygenase would explain the absence of anti-inflammatory activity.
At therapeutic doses paracetamol is well tolerated and produces fewer side effects than aspirin. The most frequently reported adverse effect associated with paracetamol is hepatotoxicity, which occurs after acute overdosage (usually doses greater than 10 to 15g are needed) and, very rarely, during long term treatment with doses at the higher levels of the therapeutic range. Paracetamol damages the liver through the formation of a highly reactive metabolite which is normally inactivated by conjugation with glutathione. Overdoses of paracetamol exhaust glutathione stores, thus allowing the accumulation of this toxic metabolite which covalently binds with vital cell elements and can result in liver necrosis. Glutathione precursors (notably intravenous N-acetylcysteine) have proved remarkably successful in treating paracetamol overdose, as long as treatment is initiated within 10 hours.
Apartfrom pharmacokinetic drug interactions resulting from changes in gastric emptying rate, there have been very few reports of clinically important drug-drug interactions involving paracetamol or phenacetin.
The pre-eminent position of paracetamol and aspirin as the non-narcotic analgesic agents of choice for mild to moderate pain is being seriously challenged by ‘newer’ non-steroidal anti-inflammatory drugs. Some of these newer agents have been found to have significantly superior analgesic activity and, in some cases, longer durations of action.
Similar content being viewed by others
References
Addy, D.P.: Cold comfort for hot children. British Medical Journal 286: 1163–1164 (1983).
American Hospital Formulary: Miscellaneous analgesics and antipyretics; in Drug Information 85, pp. 802–806 (American Society of Hospital Pharmacists, Bethesda 1985).
Arena, J.M.; Rourk, M.H. and Sibrack, C.D.: Acetaminophen: report of unusual poisoning. Pediatrics 61: 68–72 (1978).
Australian National Drug Information Service: Profile on paracetamol. Australian Journal of Pharmacy 776: 857–863 (1984).
Black, M.: Acetaminophen hepatotoxicity. Annual Reviews of Medicine 35: 577–593 (1984).
Bowman, W.C. and Rand, M.J. (Eds): Textbook of Pharmacology (2nd ed.) [Blackwell Scientific Publications, Oxford 1980].
Brodie, B.B. and Axelrod, J.: The fate of acetophenetidin (phenacetin) in man and methods for the estimation of acetophenetidin and its metabolites in biological material. Journal of Pharmacology and Experimental Therapeutics 97: 58–67 (1949).
Brune, K. and Lanz, R.: Nonopioid analgesics; in Kurhar and Pasturnak (Eds) Analgesics: Neurochemical Behavioral and Clinical Perspectives (Raven Press, New York 1984).
Cooper, S.A.: Comparative analgesic efficacies of aspirin and acetaminophen. Archives of Internal Medicine 141: 282–285 (1981).
Cooper, S.A.: New peripherally-acting oral analgesic agent. Annual Review of Pharmacology and Toxicology 23: 617–647 (1983).
Crombie, D.L.; Pinsent, R.J.F.H.; Slater, B.C.; Fleming, D. and Cross, K.W.: Teratogenic drugs — R.C.G.P. survey. British Medical Journal 4: 178–179 (1970).
Eade, N.R. and Lasagna, L.: A comparison of acetophenetidin and acetaminophen II. Subjective effects in healthy volunteers. Journal of Pharmacology and Experimental Therapeutics 155: 301–308 (1967).
Ferreira, S.H.: Peripheral and central analgesia. Pain 1: 54 (1981).
Ferreira, S.H.; Lorenzetti, B.B. and Correa, F.M.A.: Central and peripheral anti-algesic action of aspirin-like drugs. European Journal of Pharmacology 53: 39–48 (1978).
Flower, R.J.; Moncada, S. and Vane, J.R.: Analgesic-antipyretics and anti-inflammatory agents; drugs employed in the treatment of gout; in Goodman and Gilmans (Eds) The Pharmacological Basis of Therapeutics (6th ed.) pp. 682–728 (Macmillan Publishing Company, New York 1980).
Forbes, J.A.; Beaver, W.T.; White, E.H.; White, R.W.; Neilson, G.B. and Shackleford, R.W.: A new oral analgesic with an unusually long duration of action. Journal of the American Medical Association 248: 2139–2142 (1982).
Forrest, J.A.H.; Clements, J.A. and Prescott, L.F.: Clinical pharmacokinetics of paracetamol. Clinical Pharmacokinetics 7: 93–107 (1982).
Gazzard, B.G.; Ford-Hutchinson, A.W.; Smith, M.J.H. and Williams, R.: The binding of paracetamol to plasma proteins of man and pig. Journal of Pharmacy and Pharmacology 25: 964–967 (1973).
Greene, J.W.; Craft, L. and Ghishan, F.K.: Acetaminophen poisoning in infancy. American Journal of Diseases in Children 137: 386–387 (1983).
Guzman, F. and Lim, R.K.S.: Central and peripheral mechanisms of analgesia and pain. Archivos de Biologica y Medicina Experimentalis 4: 180–186 (1967).
Heel, R.C. and Avery, G.S.: Drug data information; in Avery (Ed.) Drug Treatment (2nd ed.) pp. 1211–1222 (ADIS Press, Auckland 1980).
Hinson, J.A.: Reactive metabolites of phenacetin and acetaminophen. Environmental Health Perspectives 49: 71–79 (1983).
Hollister, L.E.: Perspectives and summation of symposium, aspirin and acetaminophen. Archives of Internal Medicine 141: 404–406 (1981).
Hull Hayes, A.: Therapeutic implications of drug interactions with acetaminophen and aspirin. Archives of Internal Medicine 141: 301–304 (1981).
Hultengren, N.; Lagergren, C. and Ljungqvist, A.: Carcinoma of the renal pelvis in renal papillary necrosis. Acta Chirurgica Scandinavica 130: 314–320 (1965).
Ivey, K.J.: Gastrointestinal effects of antipyretic analgesics. American Journal of Medicine 75: 53–64 (1983).
Jackson, C.H.; MacDonald, N.C. and Cornett, J.W.D.: Acetaminophen. Canadian Medical Association Journal 131: 25–37 (1984).
Jick, H.: Effects of aspirin and acetaminophen in gastrointestinal hemorrhage. Archives of Internal Medicine 141: 316–321 (1981).
Jollow, D.J.; Thorgeirsson, S.S.; Potter, W.Z.; Hashimoto, M. and Mitchell, J.R.: Acetaminophen-induced hepatic necrosis. VI. Metabolic disposition of toxic and nontoxic doses of acetaminophen. Pharmacology 12: 251–271 (1974).
Kincaid-Smith, P.: Analgesic nephropathy. British Medical Journal 282: 1790–1791 (1970).
Kincaid-Smith, P.: Drug-induced renal disease. Practitioner 220: 862–867 (1978).
Lasagna, L.; Davis, M. and Pearson, J.W.: A comparison of acetophenetidin and acetaminophen I. Analgesic effects in postpartum patients. Journal of Pharmacology and Experimental Therapeutics 155: 296–300 (1967).
Margetts, G.: Phenacetin and paracetamol. Journal of International Medical Research 4: 55–70 (1976).
Mehlisch, D.R.: Review of the comparative analgesic efficacy of salicylates, acetaminophen, and pyrazolones. American Journal of Medicine 75: 47–52 (1983).
Meredith, T.J. and Goulding, R.: Paracetamol. Postgraduate Medical Journal 56: 459–473 (1980).
Mitchell, J.R.; Jollow, D.J.; Potter, W.Z.; Davis, D.C.; Gillette, J.R. and Brodie, B.B.: Acetaminophen-induced hepatic necrosis. IV. Role of drug metabolism. Journal of Pharmacology and Experimental Therapeutics 187: 185–194 (1973).
Mitchell, J.R.; Thorgiersson, S.S.; Potter, W.Z.; Jollow, D.J. and Keiser, H.: Acetaminophen-induced hepatic injury. Protective role of glutathione in man and rationale for therapy. Clinical Pharmacology and Therapeutics 16: 676–684 (1974).
Moertel, C.G.; Ahmann, D.L.; Taylor, W.F. and Schwartau, N.: A comparative evaluation of marketed analgesic drugs. New England Journal of Medicine 286: 813–815 (1972).
Morris, M.E. and Levy, G.: Renal clearance and serum protein binding of acetaminophen and its major conjugates in humans. Journal of Pharmaceutical Sciences 73: 1038–1041 (1984).
Mukherjee, S. and Sood, S.: A controlled evaluation of orally administered aspirin, dipyrone and placebo in patients with postoperative pain. Current Medical Research and Opinion 6: 619–623 (1980).
Neuberger, J.; Davis, M. and Williams, R.: Long-term ingestion of paracetamol and liver disease. Journal of the Royal Society of Medicine 73: 701–707 (1980).
Nogen, A.G. and Bremner, J.E.: Fatal acetaminophen overdosage in a young child. Journal of Pediatrics 92: 832–833 (1978).
Peterson, R.G. and Rumack, B.H.: Age as a variable in acetaminophen overdose. Archives of Internal Medicine 141: 390–393 (1981).
Prescott, L.F.: Gastrointestinal absorption of drugs. Medical Clinics of North America 58: 907–916 (1974).
Prescott, L.F.: Kinetics and metabolism of paracetamol and phenacetin. British Journal of Clinical Pharmacology 10: 2915–2985 (1980).
Prescott, L.F.: Analgesic nephropathy. Drugs 23: 75–149 (1982).
Prescott, L.F.: Paracetamol overdosage. Drugs 25: 290–314 (1983).
Prescott, L.F. and Critchley, J.A.J.H.: Drug interactions affecting analgesic toxicity. American Journal of Medicine 75(Suppl. 5A): 113–116 (1983).
Prescott, L.F.; Sansur, M.; Levin, W. and Conney, A.H.: The comparative metabolism of phenacetin and N-acety-p-aminophenol in man, with particular reference to effects on the kidney. Clinical Pharmacology and Therapeutics 9: 605–614 (1968).
Prescott, L.F.; Steel, R.F. and Ferrier, W.R.: The effects of particle size on the absorption of phenacetin in man: a correlation between plasma concentration of phenacetin and effects on the central nervous system. Clinical Pharmacology and Therapeutics 11: 496–504 (1970).
Ramwell, P.W.: Biologic importance of arachidonic acid. Archives of Internal Medicine 141: 275–278 (1981).
Rawlins, M.D.; Henderson, D.B. and Hijab, A.R.: Pharmacokinetics of paracetamol (acetaminophen) after intravenous and oral administration. European Journal of Clinical Pharmacology 11: 283–286 (1977).
Rumack, B.H.: Acetaminophen overdose. American Journal of Medicine 15: 104–112 (1983).
Rumack, B.H.: Acetaminophen overdose in young children. American Journal of Diseases in Children 138: 428–433 (1984).
Segasothy, M.; Kong Chiew Tong, B.; Kamel, A.; Murad, Z. and Suleiman, A.B.: Analgesic nephropathy associated with paracetamol. Australian and New Zealand Journal of Medicine 14: 23–26 (1984).
Settipane, G.A.: Adverse reactions to aspirin and related drugs. Archives of Internal Medicine 141: 328–332 (1981).
Von Mering, J.: Beiträge zur Kenntniss der Antipyretica. Therap. Monatsch 7: 577–587, (1893).
Zimmerman, H.J.: Effects of aspirin and acetaminophen on the liver. Archives of Internal Medicine 141: 333–342 (1981).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Clissold, S.P. Paracetamol and Phenacetin. Drugs 32 (Suppl 4), 46–59 (1986). https://doi.org/10.2165/00003495-198600324-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198600324-00005